STARPHARMA HLDG.SP.ADR/10 (PQ6A) — Net Asset Momentum
STARPHARMA HLDG.SP.ADR/10 (PQ6A) recorded a net asset momentum of -32.4% as of June 2025, with net assets of €19.00 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of STARPHARMA HLDG.SP.ADR/10 to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
STARPHARMA HLDG.SP.ADR/10 Net Asset Momentum (2022–2025)
This chart tracks STARPHARMA HLDG.SP.ADR/10's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -32.4%, with net assets of €19.00 Million EUR as of June 2025. Read PQ6A total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for STARPHARMA HLDG.SP.ADR/10 (2022–2025)
The table below shows the complete annual net asset history for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PQ6A market cap overview.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €19.00 Million | €25.42 Million | €6.42 Million | ▼ -32.4% |
| 2024 | €28.12 Million | €36.81 Million | €8.70 Million | ▼ -19.2% |
| 2023 | €34.81 Million | €52.09 Million | €17.27 Million | ▼ -28.1% |
| 2022 | €48.39 Million | €66.17 Million | €17.78 Million | — |